Literature DB >> 20452046

A weak association of the CLDN5 locus with schizophrenia in Chinese case-control samples.

Ning Wu, Xuan Zhang, Shunzi Jin, Shuzheng Liu, Guizhi Ju, Zhenqi Wang, Libo Liu, Lin Ye, Jun Wei.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20452046     DOI： 10.1016/j.psychres.2009.11.019

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN： 0165-1781            Impact factor:   3.222


× No keyword cloud information.
  7 in total

Review 1.  Claudins and the modulation of tight junction permeability.

Authors:  Dorothee Günzel; Alan S L Yu
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

2.  rs17501976 polymorphism of CLDN1 gene is associated with decreased risk of colorectal cancer in a Chinese population.

Authors:  Jian-Jun Chen; Ming Zhong; Tong-Hai Dou; Zhi-Yong Wu; Wei-Jun Tang
Journal:  Int J Clin Exp Med       Date:  2015-01-15

Review 3.  The Role of Brain Microvascular Endothelial Cell and Blood-Brain Barrier Dysfunction in Schizophrenia.

Authors:  Sovannarath Pong; Rakesh Karmacharya; Marianna Sofman; Jeffrey R Bishop; Paulo Lizano
Journal:  Complex Psychiatry       Date:  2020-09-14

4.  Disruption of the blood-brain barrier in 22q11.2 deletion syndrome.

Authors:  Alexis M Crockett; Sean K Ryan; Adriana Hernandez Vásquez; Caroline Canning; Nickole Kanyuch; Hania Kebir; Guadalupe Ceja; James Gesualdi; Elaine Zackai; Donna McDonald-McGinn; Angela Viaene; Richa Kapoor; Naïl Benallegue; Raquel Gur; Stewart A Anderson; Jorge I Alvarez
Journal:  Brain       Date:  2021-06-22       Impact factor: 13.501

Review 5.  Claudin-5: gatekeeper of neurological function.

Authors:  Chris Greene; Nicole Hanley; Matthew Campbell
Journal:  Fluids Barriers CNS       Date:  2019-01-29

6.  Expression of the G72/G30 gene in transgenic mice induces behavioral changes.

Authors:  L Cheng; E Hattori; A Nakajima; N S Woehrle; M D Opal; C Zhang; K Grennan; S C Dulawa; Y-P Tang; E S Gershon; C Liu
Journal:  Mol Psychiatry       Date:  2013-01-22       Impact factor: 15.992

7.  Dose-dependent expression of claudin-5 is a modifying factor in schizophrenia.

Authors:  C Greene; J Kealy; M M Humphries; Y Gong; J Hou; N Hudson; L M Cassidy; R Martiniano; V Shashi; S R Hooper; G A Grant; P F Kenna; K Norris; C K Callaghan; M dN Islam; S M O'Mara; Z Najda; S G Campbell; J S Pachter; J Thomas; N M Williams; P Humphries; K C Murphy; M Campbell
Journal:  Mol Psychiatry       Date:  2017-10-10       Impact factor: 15.992
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.